Semaglutide for type 1 diabetes with higher body weight
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes and have had it for at least 3 years.
- Your body mass index (BMI) is 30 or higher, or 27 or higher with at least one related health issue like high blood pressure or high cholesterol.
- You have not taken any GLP-1 medications (like Ozempic) in the last 6 months.
- You are not pregnant or nursing, and if you are a woman who could become pregnant, you use reliable birth control.
- You do not have current or past pancreatitis, serious liver disease, or active cancer (unless in remission for over 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether semaglutide (a weight-loss medication) works differently in people with varying degrees of insulin resistance (how well your body uses sugar). If you are obese without diabetes, you may be able to join.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
Hear when a new Obesity/Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.